Price
Financials
Standalone, Rs crore| Mar 2013 | Jun 2013 | Sep 2013 | Dec 2013 | Mar 2014 | |
|---|---|---|---|---|---|
| Sales | 54.00 | 60.31 | 67.43 | 70.13 | 69.42 |
| Expenses | 53.20 | 60.19 | 64.23 | 67.51 | 68.23 |
| Operating Profit | 0.80 | 0.12 | 3.20 | 2.62 | 1.19 |
| OPM % | 1.48% | 0.20% | 4.75% | 3.74% | 1.71% |
| Other Income | 0.55 | 0.75 | 0.92 | 0.83 | -5.39 |
| Interest | 0.64 | 0.58 | 0.46 | 0.39 | 0.35 |
| Depreciation | 1.95 | 2.24 | 2.32 | 2.37 | 2.30 |
| Profit before tax | -1.24 | -1.95 | 1.34 | 0.69 | -6.85 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit | -1.24 | -1.95 | 1.34 | 0.69 | -6.85 |
| EPS in Rs | -3.67 | -5.78 | 3.97 | 2.04 | -20.29 |
| Dec 2005 | Dec 2006 | Dec 2007 | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Mar 2013 15m | Mar 2014 | Mar 2015 | Mar 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 139 | 140 | 129 | 129 | 95 | 161 | 251 | 284 | 267 | 273 | 233 |
| Expenses | 137 | 140 | 135 | 147 | 106 | 164 | 247 | 273 | 261 | 286 | 253 |
| Operating Profit | 2 | 0 | -6 | -18 | -11 | -2 | 4 | 12 | 6 | -12 | -20 |
| OPM % | 1.7% | 0.3% | -5% | -14% | -12% | -1.6% | 1.5% | 4.2% | 2.1% | -4.6% | -8% |
| Other Income | 14 | 4 | 6 | 41 | -5 | 11 | 4 | 42 | -1 | 4 | 14 |
| Interest | 0 | 1 | 0 | 1 | 2 | 4 | 6 | 6 | 2 | 3 | 6 |
| Depreciation | 3 | 4 | 3 | 3 | 5 | 8 | 8 | 10 | 9 | 9 | 11 |
| Profit before tax | 13 | 0 | -4 | 20 | -23 | -4 | -6 | 37 | -7 | -20 | -22 |
| Tax % | 32% | -14% | 22% | 30% | -11% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Profit | 9 | 0 | -4 | 14 | -21 | -4 | -6 | 37 | -7 | -20 | -22 |
| EPS in Rs | 26.10 | 0.74 | -13.18 | 40.73 | -60.94 | -10.93 | -16.80 | 109.20 | -20.06 | -60.73 | -65.65 |
| Dividend Payout % | 21% | 0% | -8% | 4% | 0% | 0% | 0% | 2% | 0% | 0% | 0% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | 5% | 8% | -6% | -15% | ||
| Compounded Profit Growth | % | % | % | -27% | ||
| Stock Price CAGR | % | % | % | % | ||
| Return on Equity | -11% | -17% | -24% | -60% |
| Dec 2005 | Dec 2006 | Dec 2007 | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Reserves | 57 | 57 | 52 | 65 | 45 | 41 | 35 | 72 | 65 | 44 | 22 |
| Borrowings | 0 | 4 | 0 | 1 | 31 | 43 | 51 | 28 | 40 | 46 | 77 |
| Other Liabilities | 24 | 19 | 33 | 31 | 31 | 40 | 62 | 40 | 62 | 61 | 72 |
| Total Liabilities | 84 | 83 | 89 | 100 | 110 | 127 | 152 | 143 | 171 | 155 | 174 |
| Fixed Assets | 13 | 13 | 11 | 10 | 66 | 59 | 53 | 53 | 49 | 40 | 64 |
| CWIP | 1 | 3 | 17 | 50 | 0 | 0 | 1 | 3 | 2 | 10 | 0 |
| Investments | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 69 | 67 | 59 | 41 | 44 | 68 | 98 | 88 | 120 | 105 | 110 |
| Total Assets | 84 | 83 | 89 | 100 | 110 | 127 | 152 | 143 | 171 | 155 | 174 |
| Dec 2005 | Dec 2006 | Dec 2007 | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 7 | -3 | 3 | 11 | -24 | -7 | 7 | -7 | -7 | 11 | 3 |
| Cash from Investing Activity | -1 | -4 | -6 | -18 | -10 | 0 | -7 | 30 | -5 | -13 | -23 |
| Cash from Financing Activity | -4 | 1 | -4 | -1 | 27 | 9 | 3 | -28 | 11 | 4 | 25 |
| Net Cash Flow | 2 | -5 | -7 | -8 | -7 | 3 | 4 | -5 | -2 | 2 | 5 |
| Free Cash Flow | 4 | -7 | -12 | -20 | -34 | -6 | 3 | 20 | -12 | -2 | -20 |
| CFO/OP | 469% | -512% | -58% | -68% | 189% | 296% | 200% | 1% | -121% | -93% | -20% |
| Dec 2005 | Dec 2006 | Dec 2007 | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 37 | 43 | 50 | 27 | 54 | 42 | 45 | 42 | 73 | 56 | 70 |
| Inventory Days | 56 | 59 | 69 | 39 | 69 | 86 | 66 | 49 | 68 | 72 | 80 |
| Days Payable | 62 | 53 | 100 | 67 | 121 | 96 | 67 | 53 | 96 | 89 | 131 |
| Cash Conversion Cycle | 30 | 49 | 19 | -2 | 2 | 31 | 44 | 37 | 46 | 39 | 19 |
| Working Capital Days | 48 | 67 | 31 | 10 | 50 | 57 | -44 | 5 | 4 | -19 | -84 |
| ROCE % | 1% | -5% | 14% | -16% | -4% | -0% | 7% | 2% | -15% | -17% |
Fundamentals
Market Cap₹ Cr.
Current Price₹ 1,177
Book Value₹ 75.6
ROCE-16.6 %
ROE-60.3 %
Dividend Yield0.00 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)-15%
Compounded Profit Growth (TTM)-27%
Standalone figures.
Valuation
P/B, 3-year average9.88x
P/E, 5-year average3.41x
P/B, 5-year average6.89x
Profitability
Operating margin (excl. other income)-8.42%
Operating margin (incl. other income)-2.36%
EBITDA margin-2.36%
Pre-tax margin-9.51%
Net profit margin-9.51%
ROE-60.55%
ROCE-16.69%
ROA-13.48%
ROE, 3-year average-35.14%
ROCE, 3-year average-12.88%
ROA, 3-year average-10.13%
ROE, 5-year average-10.85%
ROCE, 5-year average1.20%
ROA, 5-year average-1.89%
ROIC (approx.)-17.28%
Other income / net worth55.31%
Growth
Sales growth (latest year)-14.67%
Sales CAGR, 3 years-6.41%
Sales CAGR, 5 years7.67%
Per share
EPS (TTM)Rs -65.65
EPS (latest year)Rs -65.65
EPS, 3-year averageRs -48.81
EPS, 5-year averageRs -10.81
Book value per shareRs 75.57
Sales per shareRs 690.66
Cash flow per shareRs 8.50
Free cash flow per shareRs -59.25
Dividend per share, 5-year averageRs 2.01
Dividends
Dividend payout, 5-year average1.84%
Efficiency
Asset turnover1.34x
Fixed asset turnover3.64x
Inventory turnover5.09x
Inventory days72 days
Debtor days70 days
Debtors turnover5.23x
Creditor days131 days
Cash conversion cycle19 days
Working capital days-84 days
Leverage
Total debtRs 77 Cr
Cash and bankRs 7 Cr
Net debtRs 69 Cr
Debt to equity3.00x
Interest coverage-2.81x
Owners' fund to total sources14.67%
Debt to assets44.03%
Cash flow
Cash from Operating Activity (latest year)Rs 3 Cr
Cash from Investing Activity (latest year)Rs -23 Cr
Cash from Financing Activity (latest year)Rs 25 Cr
Net Cash Flow (latest year)Rs 5 Cr
Free cash flow (latest year)Rs -20 Cr
FCFE (approx.: FCF + change in debt)Rs 10 Cr
Sales to cash flow81.23x
Statement figures
Net sales (TTM)Rs 233 Cr
Net sales (latest year)Rs 233 Cr
Operating profit excl. other income (latest year)Rs -20 Cr
Other income (TTM)Rs 14 Cr
EBITDA (TTM)Rs -6 Cr
PBDT (TTM)Rs -11 Cr
Profit before tax (TTM)Rs -22 Cr
Net profit (TTM)Rs -22 Cr
Net profit (latest year)Rs -22 Cr
Depreciation (TTM)Rs 11 Cr
Interest (TTM)Rs 6 Cr
Cost of goods sold (latest year)Rs 185 Cr
Total expenditure (latest year)Rs 253 Cr
Total income (latest year)Rs 247 Cr
Share capitalRs 3 Cr
ReservesRs 22 Cr
Shareholders' fundsRs 26 Cr
Total assetsRs 174 Cr
Net blockRs 64 Cr
Capital work in progressRs 0 Cr
ReceivablesRs 45 Cr
InventoryRs 36 Cr
Other liabilitiesRs 72 Cr
Shares outstanding (crore)0.34
Computed by MarketFriction from the standalone statements. Returns use average balances.
Not enough history to build valuation bands (needs two years of profits and prices).
Not enough price history.
Red flags
F-score 4 of 8| explain | Debt up, profit down Borrowings up 66% while net profit fell in 2016 |
| look | Repeated losses Net loss in each of the last two years |
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Mar 2014Sales ₹69 Cr +28.6% vs Mar 2013.
Net loss ₹7 Cr.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| SRF Ltd | 71,738 | 32.0 | 14.6 % |
| Deepak Fertilisers & Petrochemicals Corp Ltd | 16,523 | 16.8 | 11.4 % |
| Tata Chemicals Ltd | 15,638 | 3.42 % | |
| Gujarat Narmada Valley Fertilizers & Chemicals Ltd | 8,985 | 8.66 | 12.0 % |
| Tanfac Industries Ltd | 7,226 | 107 | 23.9 % |
| Gujarat Alkalies & Chemicals Ltd | 4,606 | 69.4 | 1.42 % |
| Grauer & Weil (India) Ltd | 3,744 | 23.4 | 20.6 % |
| GHCL Ltd | 3,724 | 8.16 | 17.4 % |
| J.G.Chemicals Ltd | 2,576 | 34.3 | 18.1 % |
| Thirumalai Chemicals Ltd | 1,834 | -3.15 % | |
| I G Petrochemicals Ltd | 1,801 | 22.1 | 3.11 % |
| Indo Borax & Chemicals Ltd | 1,569 | 32.0 | 15.4 % |
| Innovassynth Technologies (India) Ltd | 1,405 | -16.4 % | |
| Citurgia Biochemicals Ltd | 1,380 | % | |
| Vikram Thermo (India) Ltd | 1,320 | 30.1 | 36.2 % |
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.
Quick answers
What is the market cap of Rhodia Specialty Chemicals India Ltd(Merged)?
Rhodia Specialty Chemicals India Ltd(Merged) (506230) has a market capitalisation of Rs Cr. at the close.
What were Rhodia Specialty Chemicals India Ltd(Merged)'s latest quarterly results?
In the Mar 2014 quarter, Rhodia Specialty Chemicals India Ltd(Merged) sales was Rs 69 Cr (+28.6% vs Mar 2013) with a net loss of Rs 7 Cr.